Randomized double-blind clinical trial comparing safety and efficacy of the biosimilar BCD-022 with reference trastuzumab
Alexeev, Sergey M., Khorinko, Andrey V., Mukhametshina, Guzel Z., Shelepen, Konstantin G., Burdaeva, Olga N., Kulik, Sergey A., Satheesh, Chiradoni Thugappa, Srivastava, Kirti, Vikranth, Mummaneni, KrVolume:
20
Journal:
BMC Cancer
DOI:
10.1186/s12885-020-07247-9
Date:
December, 2020
Fichier:
PDF, 933 KB
2020